Infection
Emergence of resistance to novel β-lactam/β-lactamase inhibitor combinations in KPC-producing Klebsiella pneumoniae: clinical and genomic insights from consecutive bloodstream infections.
Matteo Boattini, Sara Comini, Guido Ricciardelli, Lisa Pastrone, Roberto Casale, Luisa Guarrasi, Rossana Cavallo, Cristina Costa, Paolo Gaibani, Gabriele Bianco
Published: 202510.1007/s15010-025-02716-4
Abstract
PURPOSE: Novel β-lactam/β-lactamase inhibitor combinations (BL/BLICs) such as ceftazidime/avibactam (CAZ/AVI), meropenem/vaborbactam (MEM/VAB), imipenem/relebactam (IMP/REL) and aztreonam/avibactam (ATM/AVI) have expanded therapeutic choices against…
Preview only. Read the full abstract at the source